Literature DB >> 9591906

Thrombolysis in the management of lower limb peripheral arterial occlusion--a consensus document. Working Party on Thrombolysis in the Management of Limb Ischemia.

.   

Abstract

The aim of this paper is to develop an intercontinental consensus on the use of thrombolytic therapy in occlusive peripheral arterial disease affecting lower limbs. A working party of self-designated angiologists, hematologists, interventional radiologists, and vascular surgeons of Europe and North America convened at 4 closed meetings. All published data known to any of the participants was entered into discussion. The working party discussed the topics outlined in this paper and a first draft was prepared in segments by members of the working party, discussed, and further revised into an interim report. It was then circulated to a number of Societies for their input. A final meeting of the Working Party together with delegates of the Societies collaborated on the definitive version of the text. The Party appreciates that in many areas the scientific evidence is not yet available. Nevertheless, it was felt that enough practical and scientific data were available to establish recommendations for clinical practice as well as for reporting results of thrombolytic therapy, which could be updated as later evidence became available. The guidelines apply only to drugs currently available for clinical use. The data are also considered to be sufficiently cogent that regulatory agencies should move to approve thrombolytic agents for intra-arterial therapy of acute lower extremity ischemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591906

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Pharmacological treatment of patients with peripheral arterial disease.

Authors:  Chin K Kim; Carsten M Schmalfuss; Richard S Schofield; David S Sheps
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Percutaneous mechanical thrombectomy in acute and subacute lower-extremity ischemia: impact of adjunctive, solely nonthrombolytic endovascular procedures.

Authors:  Friederika Fluck; Maximilian Stephan; Anne Augustin; Nicole Rickert; Thorsten Alexander Bley; Ralph Kickuth
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

3.  Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC.

Authors:  Silvia Casale; Chandra Bortolotto; Giulia Maria Stella; Andrea Riccardo Filippi; Salvatore Gitto; Olivia Maria Bottinelli; Sergio Carnevale; Patrizia Morbini; Lorenzo Preda
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

4.  Review of pharmacology and physiology in thrombolysis interventions.

Authors:  M Grace Knuttinen; Neelmini Emmanuel; Furquaan Isa; Alex W Rogers; Ron C Gaba; James T Bui; Charles A Owens
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

Review 5.  Complications and great escapes: equipment and techniques.

Authors:  Rory McPherson; Timothy Buckenham
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

6.  Bleeding complications after basilar artery fibrinolysis with tissue plasminogen activator.

Authors:  D T Cross; C P Derdeyn; C J Moran
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

7.  Economic value of thrombolysis with adjunctive abciximab in patients with subacute peripheral arterial occlusion.

Authors:  Stephan H Duda; Gunnar Tepe; Mohan Bala; Oliver Luz; Gerhard Ziemer; Kenneth Ouriel; Benjamin Pusich; Jakub Wiskirchen; Claus D Claussen; Kurt Banz
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Lower-limb vascular imaging with acoustic radiation force elastography: demonstration of in vivo feasibility.

Authors:  Douglas Dumont; Jeremy Dahl; Elizabeth Miller; Jason Allen; Brian Fahey; Gregg Trahey
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2009-05       Impact factor: 2.725

Review 9.  Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.

Authors:  Harry Messmore; Walter Jeske; William Wehrmacher; Jeanine Walenga
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Hyperbaric oxygenation combined with streptokinase for treatment of arterial thromboembolism of the lower leg.

Authors:  Slobodan Mihaljević; Ljiljana Mihaljević; Visnja Majerić-Kogler; Kresimir Oremus
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.